Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - ceftriaxone sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - ceftriaxone sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - ceftriaxone sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - ceftriaxone sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - ceftriaxone sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - ceftriaxone sodium -

Ireland - English - HPRA (Health Products Regulatory Authority)

jed pharma limited - ceftriaxone sodium - solution for injection/infusion - ceftriaxone

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ceftriaxone sodium 1.193 g (present as 1.193g ceftriaxone sodium*3.5h2o. eq 1.0793g of ceft. sodium anh or 1g ceftriaxone anh) - powder for injection - 1 g - active: ceftriaxone sodium 1.193 g (present as 1.193g ceftriaxone sodium*3.5h2o. eq 1.0793g of ceft. sodium anh or 1g ceftriaxone anh) - infections caused by pathogens sensitive to ceftriaxone e.g.: · sepsis; · meningitis; · abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts); · infections of the bones, joints, soft tissue, skin and of wounds; · infections in patients with impaired defence mechanisms; · renal and urinary tract infections; · respiratory tract infections, particularly pneumonia, and ear, nose and throat infections; · genital infections, including gonorrhoea. · perioperative prophylaxis of infections.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ceftriaxone sodium 2.385 g (present as 2.385g ceftriaxone sodium*3.5h2o. eq 2.1586g of ceft. sodium anh or 2g ceftriaxone anh) - powder for injection - 2 g - active: ceftriaxone sodium 2.385 g (present as 2.385g ceftriaxone sodium*3.5h2o. eq 2.1586g of ceft. sodium anh or 2g ceftriaxone anh) - infections caused by pathogens sensitive to ceftriaxone e.g.: · sepsis; · meningitis; · abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts); · infections of the bones, joints, soft tissue, skin and of wounds; · infections in patients with impaired defence mechanisms; · renal and urinary tract infections; · respiratory tract infections, particularly pneumonia, and ear, nose and throat infections; · genital infections, including gonorrhoea. · perioperative prophylaxis of infections.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ceftriaxone sodium 596mg (present as 0.596g ceftriaxone sodium*3.5h2o. eq 0.53965g of ceft. sodium anh or 0.5g ceftriaxone anh) - powder for injection - 500 mg - active: ceftriaxone sodium 596mg (present as 0.596g ceftriaxone sodium*3.5h2o. eq 0.53965g of ceft. sodium anh or 0.5g ceftriaxone anh) - infections caused by pathogens sensitive to ceftriaxone e.g.: · sepsis; · meningitis; · abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts); · infections of the bones, joints, soft tissue, skin and of wounds; · infections in patients with impaired defence mechanisms; · renal and urinary tract infections; · respiratory tract infections, particularly pneumonia, and ear, nose and throat infections; · genital infections, including gonorrhoea. · perioperative prophylaxis of infections.